Oxygen saturation targeting by pulse oximetry in the extremely low gestational age neonate: A quixotic quest

Research output: Contribution to journalReview article

5 Citations (Scopus)

Abstract

Purpose of review A collaboration of comparative effectiveness research trials of pulse oximeter saturation (SpO 2) targeting in extremely low-gestational-Age neonates have begun to report their aggregate results. We examine the results of those trials, collectively referred to as the Neonatal Oxygenation Prospective Meta-Analysis or NeOProM. We also discuss the uncertainties that remain and the clinical challenges that lie ahead. Recent findings The primary outcome from NeOProM was a composite of death or disability at 18-24 months corrected age. In 2016 the last of these reports was published. Although there were no differences in the primary outcome overall, analyses of secondary outcomes and data subsets following a pulse oximeter revision show significant treatment differences between targeting a lower compared with a higher SpO 2. Summary NeOProM represents the largest collaborative clinical research study of SpO 2 targets in extremely low-gestational-Age neonates. Although aggregate results give us some insight into the feasibility and efficacy of SpO 2 targeting in this population, many questions remain. A patient-level analysis, tracking individual outcomes based on actual SpO 2 experienced, may shed some light on these questions. However, finding a single optimal SpO 2 range seems unlikely.

Original languageEnglish (US)
Pages (from-to)153-158
Number of pages6
JournalCurrent Opinion in Pediatrics
Volume29
Issue number2
DOIs
StatePublished - Apr 1 2017
Externally publishedYes

Fingerprint

Oximetry
Gestational Age
Pulse
Comparative Effectiveness Research
Newborn Infant
Oxygen
Uncertainty
Meta-Analysis
Research
Population
Therapeutics
Clinical Studies

Keywords

  • comparative effectiveness research
  • extremely low gestational age neonates
  • Neonatal Oxygenation Prospective Meta-Analysis
  • oxygen saturation
  • pulse oximetry

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Oxygen saturation targeting by pulse oximetry in the extremely low gestational age neonate : A quixotic quest. / Cummings, James J.; Lakshminrusimha, Satyanarayana.

In: Current Opinion in Pediatrics, Vol. 29, No. 2, 01.04.2017, p. 153-158.

Research output: Contribution to journalReview article

@article{bcac7dbcca01481398e18c62e3bafaa5,
title = "Oxygen saturation targeting by pulse oximetry in the extremely low gestational age neonate: A quixotic quest",
abstract = "Purpose of review A collaboration of comparative effectiveness research trials of pulse oximeter saturation (SpO 2) targeting in extremely low-gestational-Age neonates have begun to report their aggregate results. We examine the results of those trials, collectively referred to as the Neonatal Oxygenation Prospective Meta-Analysis or NeOProM. We also discuss the uncertainties that remain and the clinical challenges that lie ahead. Recent findings The primary outcome from NeOProM was a composite of death or disability at 18-24 months corrected age. In 2016 the last of these reports was published. Although there were no differences in the primary outcome overall, analyses of secondary outcomes and data subsets following a pulse oximeter revision show significant treatment differences between targeting a lower compared with a higher SpO 2. Summary NeOProM represents the largest collaborative clinical research study of SpO 2 targets in extremely low-gestational-Age neonates. Although aggregate results give us some insight into the feasibility and efficacy of SpO 2 targeting in this population, many questions remain. A patient-level analysis, tracking individual outcomes based on actual SpO 2 experienced, may shed some light on these questions. However, finding a single optimal SpO 2 range seems unlikely.",
keywords = "comparative effectiveness research, extremely low gestational age neonates, Neonatal Oxygenation Prospective Meta-Analysis, oxygen saturation, pulse oximetry",
author = "Cummings, {James J.} and Satyanarayana Lakshminrusimha",
year = "2017",
month = "4",
day = "1",
doi = "10.1097/MOP.0000000000000458",
language = "English (US)",
volume = "29",
pages = "153--158",
journal = "Current Opinion in Pediatrics",
issn = "1040-8703",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Oxygen saturation targeting by pulse oximetry in the extremely low gestational age neonate

T2 - A quixotic quest

AU - Cummings, James J.

AU - Lakshminrusimha, Satyanarayana

PY - 2017/4/1

Y1 - 2017/4/1

N2 - Purpose of review A collaboration of comparative effectiveness research trials of pulse oximeter saturation (SpO 2) targeting in extremely low-gestational-Age neonates have begun to report their aggregate results. We examine the results of those trials, collectively referred to as the Neonatal Oxygenation Prospective Meta-Analysis or NeOProM. We also discuss the uncertainties that remain and the clinical challenges that lie ahead. Recent findings The primary outcome from NeOProM was a composite of death or disability at 18-24 months corrected age. In 2016 the last of these reports was published. Although there were no differences in the primary outcome overall, analyses of secondary outcomes and data subsets following a pulse oximeter revision show significant treatment differences between targeting a lower compared with a higher SpO 2. Summary NeOProM represents the largest collaborative clinical research study of SpO 2 targets in extremely low-gestational-Age neonates. Although aggregate results give us some insight into the feasibility and efficacy of SpO 2 targeting in this population, many questions remain. A patient-level analysis, tracking individual outcomes based on actual SpO 2 experienced, may shed some light on these questions. However, finding a single optimal SpO 2 range seems unlikely.

AB - Purpose of review A collaboration of comparative effectiveness research trials of pulse oximeter saturation (SpO 2) targeting in extremely low-gestational-Age neonates have begun to report their aggregate results. We examine the results of those trials, collectively referred to as the Neonatal Oxygenation Prospective Meta-Analysis or NeOProM. We also discuss the uncertainties that remain and the clinical challenges that lie ahead. Recent findings The primary outcome from NeOProM was a composite of death or disability at 18-24 months corrected age. In 2016 the last of these reports was published. Although there were no differences in the primary outcome overall, analyses of secondary outcomes and data subsets following a pulse oximeter revision show significant treatment differences between targeting a lower compared with a higher SpO 2. Summary NeOProM represents the largest collaborative clinical research study of SpO 2 targets in extremely low-gestational-Age neonates. Although aggregate results give us some insight into the feasibility and efficacy of SpO 2 targeting in this population, many questions remain. A patient-level analysis, tracking individual outcomes based on actual SpO 2 experienced, may shed some light on these questions. However, finding a single optimal SpO 2 range seems unlikely.

KW - comparative effectiveness research

KW - extremely low gestational age neonates

KW - Neonatal Oxygenation Prospective Meta-Analysis

KW - oxygen saturation

KW - pulse oximetry

UR - http://www.scopus.com/inward/record.url?scp=85010910536&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85010910536&partnerID=8YFLogxK

U2 - 10.1097/MOP.0000000000000458

DO - 10.1097/MOP.0000000000000458

M3 - Review article

C2 - 28085683

AN - SCOPUS:85010910536

VL - 29

SP - 153

EP - 158

JO - Current Opinion in Pediatrics

JF - Current Opinion in Pediatrics

SN - 1040-8703

IS - 2

ER -